T Cell News and Research

Latest T Cell News and Research

Influence of inflammatory polyarthritis on cancer incidence and survival

Patients with rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease, have a high risk of death from disease - at least double the risk of the general population, studies overwhelmingly show. Evidence has been less clear on whether RA patients are exceptionally vulnerable to dying from cancer.

27 Feb 2007

First 3-D structure from key influenza protein revealed

In 1918, 50 million people died during a worldwide influenza pandemic caused by mutation of a bird-specific strain of the influenza virus. Recently H5N1, another highly infectious avian strain has caused outbreaks of bird flu around the world.

27 Feb 2007

Gene therapy shows promise as treatment for diseased lower limbs at risk for amputation

New research suggests that gene therapy is a safe treatment method to explore in patients whose lower limbs are at risk for amputation because of poor circulation caused by blocked blood vessels.

27 Feb 2007

'Complicated' statements from Romney, Giuliani on abortion rights are 'welcome,' opinion piece says

Although it is "easy to hoot with derision" at the "awfully complicated positions" on abortion rights taken by former New York City Mayor Rudolph Giuliani (R) and former Massachusetts Gov. Mitt Romney (R), the two possible Republican presidential candidates "make sense" when listened to "with a decent sympathy," Ann Althouse, a law professor at the University of Wisconsin, writes in a New York Times opinion piece.

27 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007

siRNA delivery into human T cells and primary cells with carbon-nanotube transporters

Short pieces of RNA, known as small interfering RNA (siRNA), have the potential to become a new class of anticancer drugs if researchers can solve the problem of how to deliver these fragile molecules to cancer cells.

26 Feb 2007

Quantum rods and dots image cancer cells

Brightly fluorescent quantum dots and quantum rods are quickly becoming important tools for identifying specific molecules and cells in living systems. Two new reports demonstrate some of the ways in which cancer researchers are using these nanoscale imaging agents.

26 Feb 2007

Perfluorocarbon nanoparticles track living cells

Stem cell therapy, primarily bone marrow transplantation, plays a key role in treating leukemia and other types of cancer.

26 Feb 2007

Genetically caused deafness may be reversible by compensating for a missing protein

Emory University researchers have found that in mice, increasing the amount of the protein connexin26 in the ear's cochlea compensates for an absence of another protein, connexin30.

26 Feb 2007

U.K. Human Fertilisation and Embryology Authority approves compensation for eggs donated for research

The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports

25 Feb 2007

Research defines the cancer role for protein Gab-2

A protein known for its ability to "bridge" interactions between other cellular proteins may spur metastasis in breast cancer, the disease's deadliest stage, a study from Burnham Institute for Medical Research has found.

22 Feb 2007

New understanding of how and why Taxol works in patients with breast cancer

Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

22 Feb 2007

How stem cells are regulated

Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell.

22 Feb 2007

Scientists identify specific enzymes that make meningitis hard to fight

Two enzymes in meningitis bacteria which prevent the body from successfully fighting off the disease, and make the infection extremely virulent, have been identified in new research published today.

22 Feb 2007

First embryonic stem cell research grants approved under California Proposition 71

The California Institute for Regenerative Medicine's Independent Citizens' Oversight Committee on Friday announced the approval of the first human embryonic stem cell research grants provided under Proposition 71, the San Francisco Chronicle reports.

22 Feb 2007

Increased demand, compensation for egg donors in U.S.

The AP/Boston Globe on Monday examined how increased demand for egg donations and compensation for donors in the U.S. has prompted more young women to donate their eggs. According CDC data, about 10,000 women donated eggs to federally monitored programs in 2004, compared with 3,800 women in 1996.

22 Feb 2007

Women in the UK to trade eggs for IVF treatment

According to the fertility regulator in the UK women there will soon be able to donate their eggs for medical research.

21 Feb 2007

Pregnancy hormone prolactin gives hope to MS victims

Canadian scientists believe they may be some way to solving the mystery of why women suffering from multiple sclerosis (MS) go into remission while they are pregnant.

21 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

New test identifies suitable lymphoma patients likely to respond to new therapy

Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.

20 Feb 2007